Skip to main content
lexblog.com/lib/FW3YXVTTviewrecordjson
LEX-WK-FW3YXVTTcrawled 2024-11-27 02:47Z

EMA Clinical Data Publication Policy to Cover All New Marketing Authorization Applications, Line Extensions and Major Clinical Type II Variations Starting Q2 2025

Grant Castle · Robin Blaney · Inside EU Life Sciences · Published November 27, 2024

Work details

firm or organization
Covington & Burling LLP
published
2024-11-27

Citation

Grant Castle, Robin Blaney, EMA Clinical Data Publication Policy to Cover All New Marketing Authorization Applications, Line Extensions and Major Clinical Type II Variations Starting Q2 2025, Inside EU Life Sciences (November 27, 2024) [The Library at LexBlog, LEX-WK-FW3YXVTT, lexpid.org/FW3YXVTT]